1. Be given an overview of APOL1-associated kidney disease

2. Consider the effect of APOL1 on donor and recipient outcomes

3. Consider APOL1 testing as a part of donor evaluation

4. Discuss controversies surrounding APOL1 testing

Session date: 
11/14/2018 - 4:00pm to 5:00pm CST
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carrie Minnelli, MD